Article Listing - Genentech sales up 15%, but loss incurred

NEW DNA-BINDING DRUGS ON HORIZON

4 May 1992

UK-based computer-assisted mole-cular design specialist company Proteus International plc has announced that through Progene Partners, a 50/50 joint venture partnership...

US PUBLIC VACCINE PURCHASE THREAT

4 May 1992

Implementation of a universal public purchasing program of the USA's three required childhood vaccines could drive existing manufacturers from the...

REVENUES DECLINE, R&D UP AT SCIOS IN 1991

4 May 1992

The US biopharmaceutical company Scios Inc, which was formerly known as California Biotechnol-ogy, saw total revenues decline around 40% in...

WARNER-LAMBERT'S VIEW TO THE FUTURE

27 April 1992

The new management team at Warner-Lambert made its first presentation to the New York Society of Security Analysts this month...

MARION MERRELL DOW PROMOTIONS

27 April 1992

Stephen Nesbitt has been named corporate patent counsel for Marion Merrell Dow. And Gary Paul has been named director of...

FOREIGN-FUNDED VENTURES IN HUNGARY

27 April 1992

Hungary's MTI news agency has reported that foreign-funded ventures in the Hungarian pharmaceutical industry are currently exempt from tax in...

THAMIDOMIDE AS AN IMMUNOSUPPRESSANT

27 April 1992

Thalidomide has been shown to be safe and effective when used as an immunosuppressant in the treatment of chronic graft...

PHT AIDS TREATMENT RESULTS CONSISTENT

27 April 1992

The efficacy of a new treatment for AIDS patients, called passive hyperimmune therapy (PHT), has been described as encouraging, according...

US-UK FIRMS IN RUSSIAN PROJECT

27 April 1992

A pharmaceutical plant is to be built at Nizhniy Novgorod by UK engineering group John Brown and Upjohn of the...

US DRUGMAKERS TAX PENALIZATION

27 April 1992

Recent hearings by the US House Ways & Means trade committee focused on the pharmaceutical and chemical sectors. During these...

Showing 94311-94320 of 95558 articles